论文部分内容阅读
目的:研究急性ST段抬高型心肌梗死(STEMI)患者应用溶栓联合择期经皮冠状动脉介入(PCI)治疗的临床疗效。方法:回顾分析120例接受溶栓治疗STEMI患者的临床资料,其中,68例溶栓再通后择期PCI患者为观察组,另52例未行PCI者为对照组,比较两组的临床疗效。结果:观察组的心血管不良事件(MACE)发生率为8.82%,显著低于((P<0.05)。结论:STEMI溶栓后择期PCI能够降低MACE发生风险、改善心功能,改善临床预后,值得推广应用。
Objective: To study the clinical effect of thrombolysis combined with elective percutaneous coronary intervention (PCI) in patients with acute ST-segment elevation myocardial infarction (STEMI). Methods: The clinical data of 120 patients undergoing thrombolysis for STEMI were retrospectively analyzed. Of the 68 patients who underwent thrombolytic relapse and elective PCI, the other 52 patients were treated with PCI. The clinical efficacy of the two groups was compared. Results: The incidence of cardiovascular adverse events (MACE) in the observation group was 8.82%, which was significantly lower than that in the control group (P <0.05) .Conclusion: Elective PCI after thrombolysis with STEMI can reduce the risk of MACE, improve cardiac function and improve clinical prognosis, Worth promoting application.